Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2019

May 14, 2019

SELL
$39.99 - $53.48 $2 Million - $2.67 Million
-50,000 Closed
0 $0
Q4 2018

Feb 11, 2021

BUY
$31.54 - $46.67 $1.56 Million - $2.31 Million
49,500 Added 9900.0%
50,000 $2.05 Million
Q4 2018

Feb 14, 2019

BUY
$31.54 - $46.67 $15,770 - $23,335
500 New
500 $148,000
Q3 2018

Nov 14, 2018

SELL
$38.0 - $51.1 $391,400 - $526,330
-10,300 Closed
0 $0
Q2 2018

Feb 11, 2021

BUY
$38.7 - $50.15 $394,623 - $511,379
10,197 Added 9900.0%
10,300 $466,000
Q2 2018

Aug 14, 2018

BUY
$38.7 - $50.15 $3,986 - $5,165
103 New
103 $2,000

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.